GlassScriptPhysician profile
Sunil G Bhandarkar
NPI 1518977685
$3,426.94
in general payments reported to CMS, 2019-2025
18 companies · $664 in 2025
The $664 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $471 · 2021: $284 · 2022: $621 · 2023: $263 · 2024: $536 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $650.19 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $583.92 | 2020-2025 | Cequa |
| Alcon Vision LLC | $344.54 | 2019-2025 | Rocklatan |
| Tarsus Pharmaceuticals, INC. | $328.14 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $319.03 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $280.86 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Oyster Point Pharma, INC. | $182.73 | 2022-2024 | Tyrvaya |
| Glaukos Corporation | $142.46 | 2019 | |
| Harrow Eye, LLC | $131.26 | 2025 | Vevye |
| Ivantis, INC | $112.38 | 2019-2021 | |
| Thea Pharma INC. | $106.99 | 2024-2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $79.13 | 2019-2020 | |
| Dompe US, INC. | $77.63 | 2024 | Oxervate |
| Omeros Corporation | $28.25 | 2020-2021 | |
| Abbvie INC. | $18.31 | 2023 | Vuity, Lumigan, Alphagan P |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $15.32 | 2019 | |
| Akorn Operating Company LLC | $13.70 | 2021 | |
| Halozyme INC | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Bhandarkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.